Travere Therapeutics (TVTX) Stock Rallies Over 13% After Hours: Here's What Is Going On
Travere Therapeutics shares surged 13.44% after hours as strong revenue growth and FILSPARI sales gains outweighed earnings concerns.
Travere Therapeutics sold more medicine than expected, especially a drug called FILSPARI, which made investors excited and boosted the stock price after regular trading ended. When a company's sales grow fast like this, it shows the business is getting stronger, even if some other numbers weren't perfect.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.